Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
4,33 USD | -7,08 % | -48,02 % | -82,58 % |
10/05 | RAPT THERAPEUTICS, INC. : Guggenheim abaisse son opinion à neutre | ZM |
10/05 | RAPT THERAPEUTICS, INC. : Barclays neutre sur le dossier | ZM |
Métier
Nombre d'employés: 126
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Brian Wong
CEO | Chief Executive Officer | 52 | 01/08/15 |
Rodney Young
DFI | Director of Finance/CFO | 61 | 02/12/19 |
Jim Farmer
CTO | Chief Tech/Sci/R&D Officer | - | 04/05/22 |
William Ho
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/05/15 |
Dirk Brockstedt
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/01/18 |
Nipun Davar
CTO | Chief Tech/Sci/R&D Officer | - | 13/02 |
Investor Relations Contact | 63 | - | |
General Counsel | - | 03/05/23 | |
Adnan Rahman
PRN | Corporate Officer/Principal | - | 28/09/22 |
Shari L. Geffon
PRN | Corporate Officer/Principal | - | 04/05/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 04/12/19 |
William Rieflin
CHM | Chairman | 64 | 01/05/15 |
Wendye Robbins
BRD | Director/Board Member | 63 | 22/10/19 |
Brian Wong
CEO | Chief Executive Officer | 52 | 01/08/15 |
Michael Giordano
BRD | Director/Board Member | 66 | 01/01/18 |
Linda Kozick
BRD | Director/Board Member | 66 | 01/12/16 |
Director/Board Member | 46 | 09/11/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 34 799 702 | 32 017 440 ( 92,00 %) | 0 | 92,00 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-82,58 % | 151 M | |
+3,91 % | 109 Md | |
+10,87 % | 105 Md | |
+1,28 % | 22,25 Md | |
-13,14 % | 22,09 Md | |
-7,05 % | 18,68 Md | |
-38,36 % | 17,58 Md | |
-10,66 % | 16,85 Md | |
+3,75 % | 13,76 Md | |
+36,70 % | 12,46 Md |
- Bourse
- Actions
- Action RAPT
- Société RAPT Therapeutics, Inc.